Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04416165
Overview
To evaluate the potential usefulness of 68Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer, compared with 18F-FDG PET/CT.
Phase
N/A
Contacts
Hua Wu, PhD
wuhua1025@163.com
86 0592-2137166
Haojun Chen, PhD
leochen0821@foxmail.com
86 0592-2137166
ClinicalTrials.gov
NCT04416165Help us improve your experience